Analysis of the roles of integrin family members in lung adenocarcinoma

Analysis of the roles of integrin family members in lung adenocarcinoma - Analysis of the roles of integrin family members in lung adenocarcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050879

Enrollment

140

Registered

2023-04-20

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung adenocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who underwent surgical resection of lung adenocarcinoma

Exclusion criteria

Exclusion criteria: Recurrent tumors or metastatic cancers are ruled out.

Design outcomes

Primary

Measure	Time frame
To evaluate the expression of integrin family members in cancer-associated fibroblasts in lung adenocarcinoma tissues by immunohistochemistry, and to compare it with clinicopathological factors.	—

Countries

Japan

Contacts

Public ContactChihiro Inoue

Tohoku University Department of Anatomic Pathology, Graduate School of Medicine

chihiro_inoue@med.tohoku.ac.jp0227178050

Outcome results